The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways
Open accessAbstract
In neurodegenerative diseases, the inflammatory response is mediated by activated glial cells, mainly microglia, which are the resident immune cells of the central nervous system. Activated microglial cells release proinflammatory mediators and neurotoxic factors that are suspected to cause or exacerbate these diseases. We recently demonstrated that doxycycline protects substantia nigra dopaminergic neurons in an animal model of Parkinson's disease. This effect was associated with a reduction of microglial cell activation, which suggests that doxycycline may operate primarily as an anti-inflammatory drug. In the present study, we assessed the anti-inflammatory potential of doxycycline using lipopolysaccharide (LPS)-activated primary microglial cells in culture as a model of neuroinflammation. Doxycycline attenuated the expression of key activation markers in LPS-treated microglial cultures in a concentration-dependent manner. More specifically, doxycycline treatment lowered the expression of the microglial activation marker IBA-1 as well as the production of ROS, NO, and proinflammatory cytokines (TNF-α and IL-1β). In primary microglial cells, we also found that doxycycline inhibits LPS-induced p38 MAP kinase phosphorylation and NF-kB nuclear translocation. The present results indicate that the effect of doxycycline on LPS-induced microglial activation probably occurs via the modulation of p38 MAP kinase and NF-kB signaling pathways. These results support the idea that doxycycline may be useful in preventing or slowing the progression of PD and other neurodegenerative diseases that exhibit altered glia function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro, DOX has shown anti-inflammatory properties by interfering with p38 MAP kinase and NF-κB pathways, reducing the expression of the activated microglia marker IBA-1 and inhibiting the production of the pro-oxidant and pro-inflammatory factors ROS, nitric oxide, iNOS, cyclooxygenase-2 (COX-2), IL-1β and TNF-α [280,281,282].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [280]
In the citing paper
“In vitro, DOX has shown anti-inflammatory properties by interfering with p38 MAP kinase and NF-κB pathways, reducing the expression of the activated microglia marker IBA-1 and inhibiting the production of the pro-oxidant and pro-inflammatory factors ROS, nitric oxide, iNOS, cyclooxygenase-2 (COX-2), IL-1β and TNF-α [280,281,282].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [280]
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Neuropathology of Parkinson's Disease
Forno, L. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,556
Flagged first, then by citations
Cited by
Sorted by citations
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445
Sharma, R., Khristov, V., Rising, A. C., Jha, B. S., Dejene, R., Hotaling, N. A., Li, Y., Stoddard, J., Stankewicz, C., Wan, Q., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat5580 · Cited by 367
Microglia in the Retina: Roles in Development, Maturity, and Disease
Silverman, S. M., & Wong, W. T. (2018) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034425 · Cited by 364
Singh, S., & Singh, T. G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200207120949 · Cited by 307
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Walens, A., DiMarco, A. V., Lupo, R., Kroger, B. R., Damrauer, J. S., & Alvarez, J. V. (2019) · eLife · doi:10.7554/elife.43653 · Cited by 205
The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease
Calderaro, A., Patanè, G. T., Tellone, E., Barreca, D., Ficarra, S., Misiti, F., & Laganà, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314835 · Cited by 208
Autophagy and apoptosis cascade: which is more prominent in neuronal death?
Gupta, R. V., Ambasta, R. K., & Kumar, P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04004-4 · Cited by 173
Nouri, Z., Fakhri, S., El‐Senduny, F. F., Sanadgol, N., Abdel‐Ghani, G. E., Farzaei, M. H., & Chen, J. (2019) · Biomolecules · doi:10.3390/biom9110690 · Cited by 173
González-Lizárraga, F., Socías, S. B., Ávila, C. L., Torres-Bugeau, C. M., Barbosa, L. R. S., Binolfi, A., Sepúlveda-Díaz, J. E., Del-Bel, E., Fernandez, C. O., Papy-Garcia, D., et al. (2017) · Scientific Reports · doi:10.1038/srep41755 · Cited by 119
Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine
Marashly, E. T., & Bohlega, S. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00333 · Cited by 124
Malko, P., Jia, X., Wood, I., & Jiang, L. (2022) · Glia · doi:10.1002/glia.24311 · Cited by 115
Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
Bortolanza, M., Nascimento, G. C., Socías, S. B., Ploper, D., Chehín, R. N., Raisman‐Vozari, R., & Bel, E. A. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1913-1 · Cited by 104
Colombo, G., Cubero, R. J. A., Kanari, L., Venturino, A., Schulz, R., Scolamiero, M., Agerberg, J., Mathys, H., Tsai, L.-H., Chachólski, W., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01167-6 · Cited by 100
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease
Yates, P. A., Newman, S. A., Oshry, L. J., Glassman, R. H., Leone, A. M., & Reichel, E. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620951053 · Cited by 90
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Kip, E., & Parr‐Brownlie, L. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101618 · Cited by 89
Wang, Y., Wang, M., Xu, M., Li, T., Fan, K., Yan, T., Xiao, F., Bi, K., & Jia, Y. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.042 · Cited by 86
Dolatshahi, M., Hameghavandi, M. H. R., Sabahi, M., & Rostamkhani, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15242 · Cited by 87
Doxycycline Inhibits α-Synuclein-Associated Pathologies in Vitro and in Vivo
Dominguez-Meijide, A., Parrales, V., Vasili, E., González-Lizárraga, F., König, A., Lázaro, D. F., Lannuzel, A., Haik, S., Del Bel, E., Chehín, R., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105256 · Cited by 81
The neuroprotective effect of doxycycline on neurodegenerative diseases
Santa-Cecília, F. V., Leite, C. A., Del-Bel, E., & Raisman-Vozari, R. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00015-z · Cited by 73
Antibiotic Chlortetracycline Causes Transgenerational Immunosuppression via NF-κB
Qiu, W., Chen, B., Tang, L., Zheng, C., Xu, B., Liu, Z., Magnuson, J. T., Zhang, S., Schlenk, D., Xu, E. G., et al. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c07343 · Cited by 76
Tosato, M., & Marco, V. D. (2019) · Biomolecules · doi:10.3390/biom9070269 · Cited by 71
Acuña, L., Hamadat, S., Corbalán, N. S., González-Lizárraga, F., dos-Santos-Pereira, M., Rocca, J., Sepúlveda Díaz, J., Del-Bel, E., Papy-García, D., Chehín, R. N., et al. (2019) · Cells · doi:10.3390/cells8080776 · Cited by 62
Self-citationPariset, E., Malkani, S., Cekanaviciute, E., & Costes, S. V. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1820598 · Cited by 61
Anti-Inflammatory Activity of Bilberry (Vaccinium myrtillus L.)
Sharma, A., & Lee, H. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100313 · Cited by 59
Microglial glutamate release evoked by α‐synuclein aggregates is prevented by dopamine
Pereira, M. D. S., Acuña, L., Hamadat, S., Rocca, J., González‐Lizárraga, F., Chehín, R. N., Sepulveda-Diaz, J. E., Bel, E. A. D., Raisman‐Vozari, R., & Michel, P. P. (2018) · Glia · doi:10.1002/glia.23472 · Cited by 60
Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
Paldino, E., Balducci, C., Vitola, P. L., Artioli, L., D’Angelo, V., Giampà, C., Artuso, V., Forloni, G., & Fusco, F. R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01847-8 · Cited by 56
Socías, S. B., González‐Lizárraga, F., Ávila, C. L., Vera, C., Acuña, L., Sepulveda-Diaz, J. E., Bel, E. A. D., Raisman‐Vozari, R., & Chehín, R. N. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.12.002 · Cited by 55
Park, S. Y., Yi, E. H., Kim, Y., & Park, G. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s195218 · Cited by 55
Yadav, R. K., Mehan, S., Sahu, R., Kumar, S., Khan, A., Makeen, H. A., & Bratty, M. A. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271221084276 · Cited by 54
Yang, Z., & Yuan, C.-X. (2018) · BMC Anesthesiology · doi:10.1186/s12871-018-0607-4 · Cited by 53
Huang, X., Peng, J., Pang, J., Tian, X., Li, X., Wu, Y., Li, Y., Jiang, Y. Q., & Sun, X. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00398 · Cited by 50
do Prado, A. F., Pernomian, L., Azevedo, A., Costa, R. A. P. E., Rizzi, É., Ramos, J., Leme, A. F. P., Bendhack, L. M., Tanus-Santos, J. E., & Gerlach, R. F. (2018) · Redox Biology · doi:10.1016/j.redox.2018.07.005 · Cited by 49
Singh, A., Upadhayay, S., & Mehan, S. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100139 · Cited by 47
Michels, M., Ávila, P. R. M., Pescador, B., Vieira, A. A. D. S., Abatti, M. R., Cucker, L., Borges, H. D. M., Goulart, A. I., Carvalho, C. C., Barichello, T., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1606-2 · Cited by 48
Ferro, A., Sheeler, C. A., Rosa, J. S., & Cvetanović, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.016 · Cited by 49
Zhang, N., Wei, G., Ye, J., Yang, L. C., Hong, Y., Liu, G., Zhong, H., & Cai, X. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.02.012 · Cited by 44
Chang, L., Chun-Yu, Y., Wu, H., Tian, B., Zhu, Y., Luo, C.-X., & Dong-YaZhu (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160138 · Cited by 44
Datta, A., Sarmah, D., Kaur, H., Chaudhary, A., Mounica, L., Kalia, K., Borah, A., Yavagal, D. R., & Bhattacharya, P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02761-2 · Cited by 44
Rahmani, M., Negro, S., & Barcia, E. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106237 · Cited by 43
Zhang, Y.-Q., Gao, L., Cheng, Z., Cai, J.-Y., Niu, Y.-X., Meng, W.-H., & Zhao, Q.-C. (2016) · Neurotoxicity research · doi:10.1007/s12640-016-9679-4 · Cited by 38
Ogut, D., Reel, B., Korkmaz, C. G., Arun, M. Z., Mıçılı, S. Ç., & Ergür, B. U. (2016) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2016.0022 · Cited by 41
Sesamin suppresses LPS-induced microglial activation via regulation of TLR4 expression
Udomruk, S., Kaewmool, C., Pothacharoen, P., Phitak, T., & Kongtawelert, P. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.08.020 · Cited by 39
Challenges of Repurposing Tetracyclines for the Treatment of Alzheimer’s and Parkinson’s Disease
Markulin, I., Matasin, M., Turk, V. E., & Salković-Petrisic, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02457-2 · Cited by 36
Sex Steroids, Adult Neurogenesis, and Inflammation in CNS Homeostasis, Degeneration, and Repair
Larson, T. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00205 · Cited by 39
Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
Kumari, A., Sharma, R., Shrivastava, N., Somvanshi, P., & Grover, A. (2020) · RSC Advances · doi:10.1039/d0ra04949b · Cited by 34
Petrash, C. C., Palestine, A. G., & Canto-Soler, M. V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621007 · Cited by 36
Alzheimer’s disease: From basic science to precision medicine approach
Forloni, G. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000079 · Cited by 33
Rana, A., Singh, S., Deshmukh, R. R., & Kumar, A. (2020) · Brain Injury · doi:10.1080/02699052.2020.1772508 · Cited by 33
Bortolanza, M., do Nascimento, G. C., Raisman‐Vozari, R., & Del‐Bel, E. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15439 · Cited by 33
Luo, Y., Li, X., Liu, T., Cao, Y., Zhang, J., Yaseen, A., Sun, F., Zheng, W., Jiang, Y., Si, C., et al. (2018) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2018.12.007 · Cited by 32
Pereira, M. D. S., de Abreu, G. H. D., Rocca, J., Hamadat, S., Raisman‐Vozari, R., Michel, P. P., & Bel, E. A. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.617085 · Cited by 35
Liu, P., Gao, Q., Guan, L., Sheng, W., Hu, Y., Gao, T., Jiang, J., Xu, Y., Qiao, H., Xue, X., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.620946 · Cited by 30
Filho, A. J. M. C., Cunha, N. L., Rodrigues, P. D. A., de Souza, A. G., Soares, M. V.-R., Jucá, P. M., de Queiroz, T., Clemente, D. C. D. S., Mottin, M., Andrade, C. H., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.007 · Cited by 28
Altered inflammatory response in FMRP-deficient microglia
Parrott, J. M., Oster, T., & Lee, H. Y. (2021) · iScience · doi:10.1016/j.isci.2021.103293 · Cited by 28
Fan, J., Ding, L., Xia, D., Chen, D., Jiang, P., Ge, W., Zhao, R., Guo, J., Fan, X., Xue, F., et al. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.01.005 · Cited by 26
Ferreira‐Junior, N. C., Pereira, M. D. S., Francis, N., Ramírez, P., Martorell, P., González‐Lizárraga, F., Figadère, B., Chehín, R. N., Bel, E. A. D., Raisman‐Vozari, R., et al. (2021) · Cells · doi:10.3390/cells10082163 · Cited by 27
Lin, J., Fang, S., Tang, S., Hu, M. Y., Long, Y., Ghosh, A., Sun, H., Kong, L., & Hong, H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.145 · Cited by 25
Simulation of P2X‐mediated calcium signalling in microglia
Chun, B. J., Stewart, B. D., Vaughan, D. D., Bachstetter, A. D., & Kekenes-Huskey, P. M. (2018) · The Journal of Physiology · doi:10.1113/jp277377 · Cited by 22
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects
González‐Lizárraga, F., Ploper, D., Ávila, C. L., Socías, S. B., Pereira, M. D. S., Machín, B., Bel, E. A. D., Michel, P. P., Pietrasanta, L. I., Raisman‐Vozari, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76927-0 · Cited by 23
Patnaik, S., Rai, M., Jalali, S., Agarwal, K., Badakere, A., Puppala, L., Vishwakarma, S., Balakrishnan, D., Rani, P. K., Kekunnaya, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86302-2 · Cited by 24
Pereira, M. D. S., Nascimento, G. C., Bortolanza, M., Michel, P. P., Raisman‐Vozari, R., & Bel, E. A. D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1045465 · Cited by 24
Tourville, A., Viguier, S., González‐Lizárraga, F., Tomas‐Grau, R. H., Ramírez, P., Brunel, J. M., Pereira, M. D. S., Bel, E. A. D., Chehín, R. N., Ferrié, L., et al. (2023) · Antioxidants · doi:10.3390/antiox12030575 · Cited by 24
Yadav, S., & Raj, R. G. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.07.003 · Cited by 24
Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury
Huang, P. C., Wan, H., Shao, C., Li, C., Zhang, L., & He, Y. T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.688596 · Cited by 23
Park, S. Y., Choi, M. J., Park, G., & Choi, Y. W. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3350 · Cited by 23
Mahmoudi, N. E., Rastoldo, G., Marouane, E., Péricat, D., Watabe, I., Tonetto, A., Hautefort, C., Chabbert, C., Sargolini, F., & Tighilet, B. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02222-y · Cited by 24
Mello, B. S. F., Filho, A. J. M. C., Custódio, C. S., Rodrigues, P. D. A., Carletti, J. V., Vasconcelos, S. M. M., de Sousa, F. C. F., Sanders, L. L. O., & Macêdo, D. S. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.083 · Cited by 22
Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer Cells
Chen, Y., Yang, Y., Chu, H.-R., Huang, T.-Y., Wang, S., Chen, H., Li, Z.-L., Yang, Y. S. H., Lin, H., Hercbergs, A. H., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.829788 · Cited by 22
Tetracycline derivatives resist the assembly behavior of human islet amyloid polypeptide
Xu, J., Zhao, C., Huang, X., & Du, W. (2020) · Biochimie · doi:10.1016/j.biochi.2020.04.012 · Cited by 19
Wang, Y., Zhao, X., Gao, M., Wan, X., Guo, Y., Qu, Y., Chen, Y., Li, T., Liu, H., Jiang, M., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03983-3 · Cited by 19
Shishkina, G. T., Bannova, A. V., Komysheva, N. P., & Дыгало, Н. Н. (2020) · Stress · doi:10.1080/10253890.2020.1793943 · Cited by 19
Shah, S. Z. A., Zhao, D., Taglialatela, G., Khan, S. H., Hussain, T. A., Dong, H., Lai, M., Zhou, X., & Yang, L. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0500-0 · Cited by 18
RetractedDoxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice
Chen, S., Lin, Y.-J., Wang, L.-C., Tsai, H.-Y., Yang, C., Teng, Y., & Hsu, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111670 · Cited by 18
Li, X., Khan, D., Rana, M., Hänggi, D., & Muhammad, S. (2022) · Antioxidants · doi:10.3390/antiox11122413 · Cited by 16
Filho, A. J. M. C., Mottin, M., Soares, M. V.-R., Jucá, P. M., Andrade, C. H., & Macêdo, D. S. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000585 · Cited by 17
Cognitive dysfunction induced by cranial radiotherapy: mechanisms and therapeutic methods
Li, X., & Ding, Z. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111106 · Cited by 16
Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model
Vitola, P. L., Artioli, L., Cerovic, M., Poletto, C., Dacomo, L., Leva, S., Balducci, C., & Forloni, G. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.105229 · Cited by 17
Metal-organic framework-edaravone nanoparticles for radiotherapy-induced brain injury treatment
Li, X., Hua, S., Zhong, D., Zhou, M., & Ding, Z. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122868 · Cited by 16
Ha, S. E., Bhosale, P. B., Kim, H.-H., Park, M.-Y., Abusaliya, A., Kim, G. S., & Kim, J. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44060180 · Cited by 15
Shen, S., Zhang, C., Xu, Y.-M., & Shi, C.-H. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212929 · Cited by 16
Tang, M., Li, H., Ning, J.-F., Shen, X., & Sun, X. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02198 · Cited by 13
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
Xue, J., Tao, K., Wang, W., & Wang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031641 · Cited by 19
IDH2 Deficiency in Microglia Decreases the Pro-inflammatory Response via the ERK and NF-κB Pathways
Chae, U., Kim, H. S., Kim, K., Lee, H., Lee, H., Park, J., & Lee, D. (2018) · Inflammation · doi:10.1007/s10753-018-0840-5 · Cited by 13
Al-Griw, M. A., Salter, M., & Wood, I. (2022) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2022-005 · Cited by 13
Clarke, P., Leser, J. S., & Tyler, K. L. (2021) · Journal of Virology · doi:10.1128/jvi.00835-21 · Cited by 13
Pereira, M. D. S., Santos, B. M., Giménez, R., Guimarães, F. S., Raisman‐Vozari, R., Bel, E. A. D., & Michel, P. P. (2023) · Glia · doi:10.1002/glia.24489 · Cited by 13
Flores‐León, M., Alcaraz, N., Pérez‐Domínguez, M., Torres‐Arciga, K., Rebollar‐Vega, R., Rosa-Velázquez, I. A. D. L., Arriaga-Canon, C., Herrera, L. A., Arias, C., & González‐Barrios, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02434-6 · Cited by 12
Tomas‐Grau, R. H., González‐Lizárraga, F., Ploper, D., Ávila, C. L., Socías, S. B., Besnault, P., Tourville, A., Mella, R. M., Villacé, P., Salado, C., et al. (2022) · Cells · doi:10.3390/cells11172759 · Cited by 12
Hong, C. R., Lee, E. H., Jung, Y. H., Lee, J.-H., Paik, H., Hong, S.-C., & Choi, S. J. (2023) · Antioxidants · doi:10.3390/antiox12081636 · Cited by 12
Patil, V., O'Connell, E., Quinlan, L., Fearnhead, H., McMahon, S., & Pandit, A. (2020) · iScience · doi:10.1016/j.isci.2021.102182 · Cited by 11
Astrocytes, a Promising Opportunity to Control the Progress of Parkinson’s Disease
Sánchez, A., Moráles, I., Rodriguez‐Sabate, C., Solé-Sabater, M., & Rodrı́guez, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101341 · Cited by 12
Repurposing of Chemotherapeutics to Combat COVID-19
Nandi, S., Nayak, B. S., Khede, M. K., & Saxena, A. K. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221130142517 · Cited by 11
Sharma, S. K., Bhatt, P., Asdaq, S. M. B., Alshammari, M. K., Alanazi, A., Alrasheedi, N. S., Alrashdi, B. A., Alyami, S. S., Alhazmi, B. H., Alam, P., et al. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.03.014 · Cited by 10
Modulation of microglia activation by the ascorbic acid transporter SVCT2
Marino, A. L., Rex, T. S., & Harrison, F. E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.003 · Cited by 9
Upmark, F., Sjöqvist, H., Hayes, J., Dalman, C., & Karlsson, H. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01574-6 · Cited by 9
Liu, S., Tu, X., Chen, X., Mo, L., Liu, Y., Xu, J., Deng, M., & Wu, Y. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109522 · Cited by 9
Differential response of pineal microglia to surgical versus pharmacological stimuli
Rodriguez, M. P. I., Galiana, M. D., Rasmussen, J., Freites, C. L., Noctor, S. C., & Muñoz, E. M. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24505 · Cited by 10
Ploper, D., Pernicone, A. O., Tomas‐Grau, R. H., Manzano, V. E., Socías, S. B., Terán, M. D. M., Isa, V. B., Sosa‐Padilla, B., González‐Lizárraga, F., Ávila, C. L., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00169 · Cited by 8
Role of gut dysbiosis in drug-resistant epilepsy: Pathogenesis and available therapeutic strategies
Khedpande, N., & Barve, K. H. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149385 · Cited by 8
Metadata
- Authors
- Santa-Cecília, F. V., Socias, B., Ouidja, M. O., Sepulveda-Diaz, J. E., Acuña, L., Silva, R. L., Michel, P. P., Del-Bel, E., Cunha, T. M., & Raisman-Vozari, R.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- National University of Tucumán (AR)
- Universidade de São Paulo (BR)
- ORCID
- Venue
- Neurotoxicity Research
- Published
- 2016-01-08
- Volume
- 29
- Issue
- 4
- Pages
- 447-459
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- OpenAlex
- W2232460448
- Cited by
- 165
- References
- 81
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 12 · 2023: 15 · 2022: 31 · 2021: 29 · 2020: 17 · 2019: 13 · 2018: 14 · 2017: 12 · 2016: 2
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (tdm)
- Locations
- Neurotoxicity Research (publishedVersion)
- PubMed (publishedVersion)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Funders
- MINCyT-ECOS Program (A12S02)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2011/19670-0, 2013/08216-2)
- Investissements d’avenir (ANR-10-IAIHU-06)
- Translational Research Infrastructure for Biotherapies in Neurosciences (ANR-11-INBS-0011-NeurATRIS)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- doxycycline, microglial activation, neuroinflammation, p38 MAPK, NF-κB signaling, lipopolysaccharide, Parkinson's disease, anti-inflammatory activity, Iba1, reactive oxygen species, nitric oxide, TNF-α, IL-1β, substantia nigra dopaminergic neurons, neurodegenerative diseases
- MeSH terms
- Nucleophosmin, Animals, Anti-Bacterial Agents, Brain, Calcium-Binding Proteins, Cell Survival, Cells, Cultured, Doxycycline, Drug Interactions, Glial Fibrillary Acidic Protein, Lipopolysaccharides, Microfilament Proteins, Nitric Oxide, Nuclear Proteins, Signal Transduction, Macrophage-1 Antigen, Cytokines, NF-kappa B, Reactive Oxygen Species, Microglia, p38 Mitogen-Activated Protein Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review